Related Experiment Video
Updated: Nov 17, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.7K
Maturation Block in Childhood Cancer
Sam Behjati1,2,3, Richard J Gilbertson4, Stefan M Pfister5,6,7
1Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Cancer Discovery
|February 16, 2021
Summary
Childhood tumors originate from aberrant development, unlike adult cancers from accumulated damage. Targeting the developmental block in pediatric cancer cells may advance treatments beyond current cytotoxic strategies.
Area of Science:
- Oncology
- Developmental Biology
- Cancer Research
Background:
- Adult cancers arise from accumulated cellular damage and mutations in aging tissues.
- Childhood tumors originate from abnormal tissue development, presenting distinct biological characteristics.
- Pediatric cancer cells exhibit a unique block in developmental maturation.
Discussion:
- The cellular origin of cancer differs significantly between pediatric and adult populations.
- Understanding these origin differences is crucial for developing targeted therapies.
- The developmental block in childhood tumor cells presents a potential therapeutic vulnerability.
Key Insights:
- Childhood tumors arise from aberrantly developing tissues, not accumulated damage.
- Pediatric cancer cells possess a unique characteristic: a block in developmental maturation.
- This developmental block is a key differentiator from adult cancers.
Outlook:
- Targeting the developmental maturation block could lead to novel pediatric cancer treatments.
- This approach may offer alternatives to traditional cytotoxic chemotherapy.
- Further research into developmental pathways could revolutionize childhood cancer therapy.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
02:34Inhibition of Cdk Activity
5.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
02:07Tumor Progression
6.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
89
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
03:03mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K